Innovative Therapies, Diagnostics, And Events Propel These Hot Promising Small Caps – Yahoo Finance

The company’s stock price has jumped in recent weeks thanks to some promising data trickling in for ANAVEX 3-71. Research has shown that the drug may be effective for reducing synaptic loss in Alzheimer’s patients, meaning an increase in cognition for patients suffering from a disease with few other alternative medicines. Another surging stock on the horizon is CD International Enterprises ( CDII ), an industrial commodities and corporate consulting company based in China and the Americas whose price soared over 4,000 percent at the height of trading last week, based on the news that the company received a purchase order of 240K tons of copper concentrate, valued at $350M. Given recent fluctuations in global markets, the time may be right for investors to take a flier on smaller stocks with big aspirations and even bigger innovations. Given its recent progress, Cannabis Biosciences (CBIS) can be viewed as a spearheading force in a small group of companies that may currently developing the future of biotech treatments and diagnostic therapies. Seraphim Strategies is a third party publisher. Not a registered broker/dealer/analyst/adviser, holds no investment licenses and may not sell, offer to sell or offer to buy any security. Market updates, news alerts and corporate profiles are not a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is not to be interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. For full disclaimer please read http://tomorrowsbluechips.com/disclaimer/ This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.

To read more visit http://finance.yahoo.com/news/innovative-therapies-diagnostics-events-propel-125000079.html

Share This Post

Recent Articles

Leave a Reply

© 2018 Medical Marijuana Stocks. All rights reserved. Site Admin · Entries RSS · Comments RSS
Powered by WordPress · Designed by Theme Junkie